THE DEAL, AT A GLANCE
From the announcementA new immuno-oncology play
01Who is involvedBacked by your inboxFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedA new immuno-oncology play raised $225M, announced 2026-09-09From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersA new immuno-oncology play’s $225M financing is a top-decile Healthcare & Life Sciences round within the tracked Capvizr set, indicating that large private capital…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
A new immuno-oncology play · Financing Record
Explore source-linked visual explanations for A new immuno-oncology play. Unsupported claims are withheld while source review continues.
Record 12178 · Recorded date: 2026-09-09
Explore company records →